ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance.
Saved in:
| Title: | ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. |
|---|---|
| Authors: | Wahlster L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Godley LA; Division of Hematology/Oncology, Lurie Children's Hospital, Northwestern Medicine, Chicago, IL., Cheng JX; Department of Pathology, The University of Chicago, Chicago, IL., Drazer MW; Sections of Hematology/Oncology and Genetic Medicine, Department of Medicine, The University of Chicago Comprehensive Cancer Center, Chicago, IL., Reilly CR; Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Rowe JH; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Weichert-Leahey N; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rowe RG; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gorfinkel L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Brundige K; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wachter F; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Messa L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Michelson AD; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Cantor AB; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Shimamura A; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Bledsoe JR; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA. |
| Source: | Blood [Blood] 2025 Jul 10; Vol. 146 (2), pp. 254-259. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40331912 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wahlster+L%22">Wahlster L</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Godley+LA%22">Godley LA</searchLink>; Division of Hematology/Oncology, Lurie Children's Hospital, Northwestern Medicine, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Cheng+JX%22">Cheng JX</searchLink>; Department of Pathology, The University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Drazer+MW%22">Drazer MW</searchLink>; Sections of Hematology/Oncology and Genetic Medicine, Department of Medicine, The University of Chicago Comprehensive Cancer Center, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Reilly+CR%22">Reilly CR</searchLink>; Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Pinkus+GS%22">Pinkus GS</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Rowe+JH%22">Rowe JH</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Weichert-Leahey+N%22">Weichert-Leahey N</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Rowe+RG%22">Rowe RG</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gorfinkel+L%22">Gorfinkel L</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Brundige+K%22">Brundige K</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Wachter+F%22">Wachter F</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Messa+L%22">Messa L</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Michelson+AD%22">Michelson AD</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cantor+AB%22">Cantor AB</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Shimamura+A%22">Shimamura A</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bledsoe+JR%22">Bledsoe JR</searchLink>; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Jul 10; Vol. 146 (2), pp. 254-259. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40331912 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2024027368 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 254 Titles: – TitleFull: ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wahlster L – PersonEntity: Name: NameFull: Godley LA – PersonEntity: Name: NameFull: Cheng JX – PersonEntity: Name: NameFull: Drazer MW – PersonEntity: Name: NameFull: Reilly CR – PersonEntity: Name: NameFull: Pinkus GS – PersonEntity: Name: NameFull: Rowe JH – PersonEntity: Name: NameFull: Weichert-Leahey N – PersonEntity: Name: NameFull: Rowe RG – PersonEntity: Name: NameFull: Gorfinkel L – PersonEntity: Name: NameFull: Brundige K – PersonEntity: Name: NameFull: Wachter F – PersonEntity: Name: NameFull: Messa L – PersonEntity: Name: NameFull: Michelson AD – PersonEntity: Name: NameFull: Cantor AB – PersonEntity: Name: NameFull: Shimamura A – PersonEntity: Name: NameFull: Bledsoe JR IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 2025 Jul 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 146 – Type: issue Value: 2 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |